Skip to main content

Content Section

5 big advantages of Insulin Pumps

Why switch to an insulin pump?

Advantages of insulin pumps

Overall, pump therapy is a great alternative for managing your diabetes. In fact, the majority of people who change to an insulin pump don't go back to injections.1

 

Why switch to a pump?

There are plenty of reasons. Here are our top 5.

 

1

Lower A1c levels


Studies show that people who use insulin pumps have lower A1c levels—a measure of blood sugar control over time—than those who take multiple daily injections.2

 

2

Fewer hypoglycemic episodes


Pumpers have been shown to experience fewer episodes of severe hypoglycemia than those who take injections, including during the night.3

 

3

Fewer injections


Intensive therapy with multiple daily injections can add up to as many as 1,460 needle sticks a year. Meanwhile, insulin pumps require an infusion set change only about three times a week, or 156 insertions a year.

 

4

More flexibility


Insulin pumps like the OneTouch® Ping® glucose management system are designed to keep up with schedules that change from day to day.

Unlike multiple injections, the pump gives you the freedom to sleep in, decide when and if you want to eat, choose when and how long to exercise, and so on—no "clock watching" required.

 

5

Fine-tuned control, every day


All kinds of things can affect good control—from stress to illness to travel. Pumps help make things more manageable by enabling you to adjust your insulin at any time to meet these different challenges.

 

 

The information made available on the Animas website is not intended to be used or viewed as a substitute for consultation with a healthcare professional. The information provided on this site cannot be the basis for diagnosis or therapy. You are advised to obtain professional advice and should always discuss your treatment plan with your healthcare team.

1 Weisberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy. Diabetes Care. 2003;26(4):1079-1087.

2 Hoogma RPLM, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, et al. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med. 2005;23:141-147.

3 Bode BW, Sabbah HT, Gross TM, Fredrickson LP, Davidson PC. Diabetes management in the new millennium using insulin pump therapy. Diabetes Metab Res Rev. 2002;18(suppl 1):S14-S20.